The pig: a model for human infectious diseases

被引:745
作者
Meurens, Francois [1 ]
Summerfield, Artur [2 ]
Nauwynck, Hans [3 ]
Saif, Linda [4 ]
Gerdts, Volker [5 ]
机构
[1] INRA, Unite Rech 1282, F-37380 Tours, France
[2] Inst Virol & Immunoprophylaxis IVI, CH-3147 Mittelhausern, Switzerland
[3] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, B-9820 Merelbeke, Belgium
[4] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Vet Prevent Med, Food Anim Hlth Res Program, Wooster, OH 44691 USA
[5] Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK S7N 5E3, Canada
关键词
HUMAN ROTAVIRUS INFECTION; ANIMAL-MODELS; BORDETELLA-PERTUSSIS; MATERNAL IMMUNITY; SWINE; INFLUENZA; CELL; RESPONSES; PATHOGENESIS; REPLICATION;
D O I
10.1016/j.tim.2011.11.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
An animal model to study human infectious diseases should accurately reproduce the various aspects of disease. Domestic pigs (Sus scrofa domesticus) are closely related to humans in terms of anatomy, genetics and physiology, and represent an excellent animal model to study various microbial infectious diseases. Indeed, experiments in pigs are much more likely to be predictive of therapeutic treatments in humans than experiments in rodents. In this review, we highlight the numerous advantages of the pig model for infectious disease research and vaccine development and document a few examples of human microbial infectious diseases for which the use of pigs as animal models has contributed to the acquisition of new knowledge to improve both animal and human health.
引用
收藏
页码:50 / 57
页数:8
相关论文
共 80 条
[41]   2009 Pandemic H1N1 Influenza Virus Causes Disease and Upregulation of Genes Related to Inflammatory and Immune Responses, Cell Death, and Lipid Metabolism in Pigs [J].
Ma, Wenjun ;
Belisle, Sarah E. ;
Mosier, Derek ;
Li, Xi ;
Stigger-Rosser, Evelyn ;
Liu, Qinfang ;
Qiao, Chuanling ;
Elder, Jake ;
Webby, Richard ;
Katze, Michael G. ;
Richt, Juergen A. .
JOURNAL OF VIROLOGY, 2011, 85 (22) :11626-11637
[42]   Pathogenicity of swine influenza viruses possessing an avian or swine-origin PB2 polymerase gene evaluated in mouse and pig models [J].
Ma, Wenjun ;
Lager, Kelly M. ;
Li, Xi ;
Janke, Bruce H. ;
Mosier, Derek A. ;
Painter, Laura E. ;
Ulery, Eva S. ;
Ma, Jingqun ;
Lekcharoensuk, Porntippa ;
Webby, Richard J. ;
Richt, Juergen A. .
VIROLOGY, 2011, 410 (01) :1-6
[43]  
Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797
[44]   PB2 Protein of a Highly Pathogenic Avian Influenza Virus Strain A/chicken/Yamaguchi/7/2004 (H5N1) Determines Its Replication Potential in Pigs [J].
Manzoor, Rashid ;
Sakoda, Yoshihiro ;
Nomura, Naoki ;
Tsuda, Yoshimi ;
Ozaki, Hiroichi ;
Okamatsu, Masatoshi ;
Kida, Hiroshi .
JOURNAL OF VIROLOGY, 2009, 83 (04) :1572-1578
[45]   Human noroviruses in swine and cattle [J].
Mattison, Kirsten ;
Shukla, Anu ;
Cook, Angela ;
Pollari, Frank ;
Friendship, Robert ;
Kelton, David ;
Bidawid, Sabah ;
Farber, Jeffrey M. .
EMERGING INFECTIOUS DISEASES, 2007, 13 (08) :1184-1188
[46]   Dendritic cells - At the front-line of pathogen attack [J].
McCullough, Kenneth C. ;
Ruggli, Nicolas ;
Summerfield, Artur .
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2009, 128 (1-3) :7-15
[47]   A STUDY OF SUBGROSS PULMONARY ANATOMY IN VARIOUS MAMMALS [J].
MCLAUGHLIN, R ;
CANADA, RO ;
TYLER, WS .
AMERICAN JOURNAL OF ANATOMY, 1961, 108 (02) :149-&
[48]   Adaptive strategies of the influenza virus polymerase for replication in humans [J].
Mehle, Andrew ;
Doudna, Jennifer A. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (50) :21312-21316
[49]   TH1-CELL AND TH2-CELL - DIFFERENT PATTERNS OF LYMPHOKINE SECRETION LEAD TO DIFFERENT FUNCTIONAL-PROPERTIES [J].
MOSMANN, TR ;
COFFMAN, RL .
ANNUAL REVIEW OF IMMUNOLOGY, 1989, 7 :145-173
[50]   Species specialization in cytokine biology: Is interleukin-4 central to the TH1-TH2 paradigm in swine? [J].
Murtaugh, Michael P. ;
Johnson, Craig R. ;
Xiao, Zhengguo ;
Scamurra, Ronald W. ;
Zhou, Yaling .
DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2009, 33 (03) :344-352